Published in J Am Acad Child Adolesc Psychiatry on August 01, 2002
European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry (2004) 3.22
Alcoholism is a disinhibitory disorder: neurophysiological evidence from a Go/No-Go task. Biol Psychol (2004) 1.42
Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry (2004) 1.38
Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J Abnorm Psychol (2012) 1.31
Comorbidity of tic disorders & ADHD: conceptual and methodological considerations. Eur Child Adolesc Psychiatry (2007) 1.00
Response inhibition deficits in externalizing child psychiatric disorders: an ERP-study with the Stop-task. Behav Brain Funct (2005) 0.97
Spatial-anatomical mapping of NoGo-P3 in the offspring of alcoholics: evidence of cognitive and neural disinhibition as a risk for alcoholism. Clin Neurophysiol (2005) 0.97
Neurocognitive deficits in male alcoholics: an ERP/sLORETA analysis of the N2 component in an equal probability Go/NoGo task. Biol Psychol (2011) 0.95
Improving antisaccade performance in adolescents with attention-deficit/hyperactivity disorder (ADHD). Exp Brain Res (2006) 0.89
Neuronal network models of ADHD -- lateralization with respect to interhemispheric connectivity reconsidered. Eur Child Adolesc Psychiatry (2004) 0.88
Influence of alcohol use on neural response to Go/No-Go task in college drinkers. Neuropsychopharmacology (2013) 0.88
Electrophysiological markers of genetic risk for attention deficit hyperactivity disorder. Expert Rev Mol Med (2011) 0.84
Time processing in children and adults with ADHD. J Neural Transm (Vienna) (2010) 0.83
Alterations in neural processing and psychopathology in children raised in institutions. Arch Gen Psychiatry (2012) 0.83
Dopamine inactivation efficacy related to functional DAT1 and COMT variants influences motor response evaluation. PLoS One (2012) 0.80
Children with oppositional-defiant disorder display deviant attentional processing independent of ADHD symptoms. J Neural Transm (Vienna) (2005) 0.80
Predicting acute side effects of stimulant medication in pediatric attention deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a continuous-performance test. Neuropsychiatr Dis Treat (2013) 0.77
Delta, theta, and alpha event-related oscillations in alcoholics during Go/NoGo task: Neurocognitive deficits in execution, inhibition, and attention processing. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.76
Time-resolved influences of functional DAT1 and COMT variants on visual perception and post-processing. PLoS One (2012) 0.75
Performance Monitoring in Medication-Naïve Children with Tourette Syndrome. Front Neurosci (2016) 0.75
EUNETHYDIS -- searching for valid aetiological candidates of Attention-Deficit Hyperactivity Disorder or Hyperkinetic Disorder. Eur Child Adolesc Psychiatry (2004) 0.75
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry (2013) 5.89
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry (2004) 3.22
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry (2009) 3.01
Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet (2008) 2.53
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry (2006) 2.49
Multicultural assessment of child and adolescent psychopathology with ASEBA and SDQ instruments: research findings, applications, and future directions. J Child Psychol Psychiatry (2008) 2.48
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry (2009) 2.47
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) (2008) 2.43
Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 2.40
Obsessive-compulsive disorder in children and adolescents. Dtsch Arztebl Int (2011) 2.10
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
Strong genetic evidence of DCDC2 as a susceptibility gene for dyslexia. Am J Hum Genet (2005) 1.94
Testing the 8-syndrome structure of the child behavior checklist in 30 societies. J Clin Child Adolesc Psychol (2007) 1.94
Normative data and scale properties of the German parent SDQ. Eur Child Adolesc Psychiatry (2004) 1.88
Co-existing disorders in ADHD -- implications for diagnosis and intervention. Eur Child Adolesc Psychiatry (2004) 1.88
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry (2011) 1.86
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med (2007) 1.85
Neurofeedback in children with ADHD: specific event-related potential findings of a randomized controlled trial. Clin Neurophysiol (2010) 1.73
Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry (2011) 1.70
A neurophysiological marker of impaired preparation in an 11-year follow-up study of attention-deficit/hyperactivity disorder (ADHD). J Child Psychol Psychiatry (2012) 1.65
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry (2011) 1.56
DSM-IV combined type ADHD shows familial association with sibling trait scores: a sampling strategy for QTL linkage. Am J Med Genet B Neuropsychiatr Genet (2008) 1.50
Fine motor skills and interhemispheric transfer in treatment-naive male children with Tourette syndrome. Dev Med Child Neurol (2012) 1.49
Prevalence of mental health problems among children and adolescents in Germany: results of the BELLA study within the National Health Interview and Examination Survey. Eur Child Adolesc Psychiatry (2008) 1.49
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
[Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry]. Z Kinder Jugendpsychiatr Psychother (2012) 1.46
Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry (2010) 1.46
Performance variability, impulsivity errors and the impact of incentives as gender-independent endophenotypes for ADHD. J Child Psychol Psychiatry (2009) 1.46
Validation of the parent and teacher SDQ in a clinical sample. Eur Child Adolesc Psychiatry (2004) 1.45
Catechol-O-methyltransferase Val158 Met genotype, parenting practices and adolescent alcohol use: testing the differential susceptibility hypothesis. J Child Psychol Psychiatry (2011) 1.45
The generalizability of the Youth Self-Report syndrome structure in 23 societies. J Consult Clin Psychol (2007) 1.45
Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry (2007) 1.42
Autism symptoms in Attention-Deficit/Hyperactivity Disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders. J Autism Dev Disord (2008) 1.38
Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry (2004) 1.38
Impact of age at first drink on vulnerability to alcohol-related problems: testing the marker hypothesis in a prospective study of young adults. J Psychiatr Res (2009) 1.37
Fetal alcohol spectrum disorders in young adulthood. J Pediatr (2007) 1.37
Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism. Biol Psychiatry (2009) 1.37
Coarse neural tuning for print peaks when children learn to read. Neuroimage (2006) 1.34
Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors. Arch Gen Psychiatry (2010) 1.34
Epidemiological comparisons of problems and positive qualities reported by adolescents in 24 countries. J Consult Clin Psychol (2007) 1.32
A locus on 2p12 containing the co-regulated MRPL19 and C2ORF3 genes is associated to dyslexia. Hum Mol Genet (2007) 1.32
Distinct EEG effects related to neurofeedback training in children with ADHD: a randomized controlled trial. Int J Psychophysiol (2009) 1.31
Assessing psychopathological problems of children and adolescents from 3 to 17 years in a nationwide representative sample: results of the German health interview and examination survey for children and adolescents (KiGGS). Eur Child Adolesc Psychiatry (2008) 1.30
Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.30
Mapping attention-deficit/hyperactivity disorder from childhood to adolescence--no neurophysiologic evidence for a developmental lag of attention but some for inhibition. Biol Psychiatry (2009) 1.30
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry (2013) 1.29
The Child Behavior Checklist-Dysregulation Profile predicts substance use, suicidality, and functional impairment: a longitudinal analysis. J Child Psychol Psychiatry (2010) 1.29
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies. BMC Psychiatry (2013) 1.29
Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. Int J Neuropsychopharmacol (2009) 1.28
The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behav Brain Funct (2008) 1.27
Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder. J Child Psychol Psychiatry (2009) 1.27
Child and adolescent psychiatry training in Europe: differences and challenges in harmonization. Eur Child Adolesc Psychiatry (2006) 1.27
EINAQ -- a European educational initiative on Attention-Deficit Hyperactivity Disorder and associated problems. Eur Child Adolesc Psychiatry (2004) 1.26
A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry (2012) 1.25